Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RIPLEY R HOLLISTER

Allopathic & Osteopathic Physicians Family Medicine

NPI
1790899185
CMS profile
308902
Location
COLORADO SPRINGS, CO

General Payments · PY2018–2024

$5,956.95

  • Reported across 287 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$769.50

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $769.50 35

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $207.70 7
Acerta Pharma LLC $181.80 8
PFIZER INC. $106.77 6
Boehringer Ingelheim Pharmaceuticals, Inc. $79.39 3
Novo Nordisk AS $50.84 3
Esperion Therapeutics, Inc. $37.16 2
Lilly USA, LLC $33.36 2
ABBVIE INC. $23.53 1
Astellas Pharma US Inc $19.30 1
Cleerly, Inc. $15.07 1
Exact Sciences Corporation $14.58 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,142.50 53
PY2019 $875.24 33
PY2020 $575.93 41
PY2021 $1,164.14 52
PY2022 $812.14 44
PY2023 $617.50 29
PY2024 $769.50 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $23.53 04/08/2024 Food and Beverage Undisputed 01/23/2026 1103931952 CMS
Amgen Inc. $15.93 01/23/2024 Food and Beverage Undisputed 01/23/2026 1117580800 CMS
Amgen Inc. $0.21 05/20/2024 Food and Beverage Undisputed 01/23/2026 1115727788 CMS
Amgen Inc. $4.68 05/20/2024 Food and Beverage Undisputed 01/23/2026 1115727804 CMS
Amgen Inc. $27.17 06/04/2024 Food and Beverage Undisputed 01/23/2026 1115727778 CMS
Amgen Inc. $121.07 07/11/2024 Food and Beverage Undisputed 01/23/2026 1115727769 CMS
Amgen Inc. $19.29 09/05/2024 Food and Beverage Undisputed 01/23/2026 1117580802 CMS
Amgen Inc. $19.35 12/12/2024 Food and Beverage Undisputed 01/23/2026 1117580804 CMS
Astellas Pharma US Inc $19.30 08/05/2024 Food and Beverage Undisputed 01/23/2026 1139265388 CMS
AstraZeneca Pharmaceuticals LP $21.31 02/15/2024 Food and Beverage Undisputed 01/23/2026 1104349044 CMS
AstraZeneca Pharmaceuticals LP $19.41 03/26/2024 Food and Beverage Undisputed 01/23/2026 1105255033 CMS
AstraZeneca Pharmaceuticals LP $25.58 04/23/2024 Food and Beverage Undisputed 01/23/2026 1104469924 CMS
AstraZeneca Pharmaceuticals LP $22.25 07/16/2024 Food and Beverage Undisputed 01/23/2026 1105581864 CMS
AstraZeneca Pharmaceuticals LP $21.03 08/07/2024 Food and Beverage Undisputed 01/23/2026 1104530656 CMS
AstraZeneca Pharmaceuticals LP $24.94 09/05/2024 Food and Beverage Undisputed 01/23/2026 1105860486 CMS
AstraZeneca Pharmaceuticals LP $24.79 09/19/2024 Food and Beverage Undisputed 01/23/2026 1104492726 CMS
AstraZeneca Pharmaceuticals LP $22.49 11/18/2024 Food and Beverage Undisputed 01/23/2026 1105692389 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $27.28 03/19/2024 Food and Beverage Undisputed 01/23/2026 1118157939 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $26.83 04/16/2024 Food and Beverage Undisputed 01/23/2026 1118157937 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $25.28 10/23/2024 Food and Beverage Undisputed 01/23/2026 1118157935 CMS
Cleerly, Inc. $15.07 11/14/2024 Food and Beverage Undisputed 01/23/2026 1144711940 CMS
Esperion Therapeutics, Inc. $17.93 05/21/2024 Food and Beverage Undisputed 01/23/2026 1129438768 CMS
Esperion Therapeutics, Inc. $19.23 10/24/2024 Food and Beverage Undisputed 01/23/2026 1129438770 CMS
Exact Sciences Corporation $14.58 02/19/2024 Food and Beverage Undisputed 01/23/2026 1114705960 CMS
Lilly USA, LLC $13.92 05/09/2024 Food and Beverage Undisputed 01/23/2026 1135366826 CMS
Lilly USA, LLC $19.44 09/19/2024 Food and Beverage Undisputed 01/23/2026 1135366828 CMS
Novo Nordisk Inc $14.62 02/13/2024 Food and Beverage Undisputed 01/23/2026 1096895317 CMS
Novo Nordisk Inc $17.42 06/19/2024 Food and Beverage Undisputed 01/23/2026 1096807027 CMS
Novo Nordisk Inc $18.80 08/13/2024 Food and Beverage Undisputed 01/23/2026 1097441195 CMS
PFIZER INC. $11.99 02/12/2024 Food and Beverage Undisputed 01/23/2026 1131137430 CMS
PFIZER INC. $20.19 04/30/2024 Food and Beverage Undisputed 01/23/2026 1132030181 CMS
PFIZER INC. $15.74 05/21/2024 Food and Beverage Undisputed 01/23/2026 1131548278 CMS
PFIZER INC. $12.31 06/05/2024 Food and Beverage Undisputed 01/23/2026 1131683970 CMS
PFIZER INC. $24.25 08/28/2024 Food and Beverage Undisputed 01/23/2026 1131839736 CMS
PFIZER INC. $22.29 10/07/2024 Food and Beverage Undisputed 01/23/2026 1132096053 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.